Larry Ellison表示，人工智能可用于开发基于mRNA的个性化癌症疫苗和早期肿瘤检测。他解释称，人工智能可以用来分析旨在识别血液中循环的微小肿瘤碎片的测试，在对癌变分子进行基因测序后，个体化的癌症疫苗可以在大约两天内开发出来。他表示：“一旦我们对癌症肿瘤进行基因测序，你就可以为每个人设计一种疫苗，让他们接种疫苗来对抗这种癌症。你可以在大约48小时内用人工智能机器人制造这种mRNA疫苗。”
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
